Market Introduction
The cardiovascular needles are used during a number of cardiovascular surgeries such as open-heart surgery, cardiac valve procedures, heart transplant, coronary artery bypass graft surgery, and many more surgeries need surgical needles. These cardiovascular needles are of two types: single use or eyeless needles and multiple use or eyed needles. Cardiovascular needles are manufactured from new stainless-steel alloys containing high concentrations of nickel, Surgalloy and Ethalloy.
Thus, the increasing prevalence of cardiovascular diseases are expected to create a significant demand for cardiovascular needle in the coming years, which is further anticipated to drive the cardiovascular needle market.
The coronavirus has had a significant impact in the Middle East and Africa. The pandemic has increased demand for medical devices, which can use in-home care. The region is witnessing an increase in the number of patients being admitted to intensive care units (ICU), an increasing number of drugs that pose multiple diagnostic and therapeutic challenges to strained health systems, leading to an increase in medical devices. Radiologists in South Africa have the highest number of COVID-19 infections in the country. You have seen changes in staff assignments and working hours and the implementation of strict infection control and social distancing measures. In addition, they face mental, physical, emotional, and financial challenges. Heart patients, especially those with heart failure and implantable devices, are at increased risk of COVID-19 morbidity and mortality. In addition, there is growing evidence that COVD-19 has significant and even long-term effects on the heart that can lead to an echo pandemic of patients with heart failure. With the ever-increasing costs associated with health care enrollment and the social distancing imposed by COVID-19. For this reason, market is going to have a negative impact in the review period.
Market Overview and Dynamics
The cardiovascular needle market in Middle East and Africa is expected to grow from US$ 3,968.2 thousands in 2021 to US$ 6,189.7 thousands by 2028; it is estimated to grow at a CAGR of 6.6% from 2021 to 2028. Elderly people are at a high risk of heart diseases due to weakened immunity and other health issues. In general, aging leads to stiffening of heart muscles and blood vessels; moreover, the systolic blood pressure rises with aging. Thus, the people with the age 75 and above commonly suffer from hypertension, which may subsequently cause coronary artery disease and heart failure. According to the United Nation’s World Population Ageing 2017 report, around 962 million people were aged 60 years or above, and the number is expected to reach ~2.1 billion by 2050. The elderly population is known to have an atypical presentation of illness along with comorbidities and unfavourable outcomes. The major reason for the disease is related to age-related structural and functional changes in the cardiovascular system. Thus, the rising geriatric population, coupled with the surge in CVD prevalence among these people, is driving the cardiovascular needles market growth.
Key Market Segments
In terms of type, the round-bodied needles segment accounted for the largest share of the Middle East and Africa cardiovascular needle market in 2020. In terms of application, the open-heart surgery segment accounted for the largest share of the Middle East and Africa cardiovascular needle market in 2020. In terms of usage, the single use segment accounted for the largest share of the Middle East and Africa cardiovascular needle market in 2020. In terms of end user, the hospitals and clinics segment accounted for the largest share of the Middle East and Africa cardiovascular needle market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the cardiovascular needle market in Middle East and Africa are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Ethicon (Johnson & Johnson Services, Inc.), MANI, INC., Barber of Sheffield, FSSB surgical needles GmbH, Medtronic, Teleflex Incorporated, Meril Life Sciences Pvt. Ltd., CP Medical, and SMB Corporation of India.
Reasons to buy report
Middle East and Africa Cardiovascular Needle Market Segmentation
By Application
By Usage
By End User
By Country
Companies Mentioned
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 3,968.2 thousand |
| Market Size by 2028 | US$ 6,189.7 thousand |
| CAGR (2021 - 2028) | 6.6% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
Middle East and Africa
|
| Market leaders and key company profiles |
|
The Middle East and Africa Cardiovascular Needle Market is valued at US$ 3,968.2 thousand in 2021, it is projected to reach US$ 6,189.7 thousand by 2028.
As per our report Middle East and Africa Cardiovascular Needle Market, the market size is valued at US$ 3,968.2 thousand in 2021, projecting it to reach US$ 6,189.7 thousand by 2028. This translates to a CAGR of approximately 6.6% during the forecast period.
The Middle East and Africa Cardiovascular Needle Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Cardiovascular Needle Market report:
The Middle East and Africa Cardiovascular Needle Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Cardiovascular Needle Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Cardiovascular Needle Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)